cln-081
cullinan oncology,otsuka
['sclc', 'lung', 'cln-081 ', 'nsclc']
data from the phase 1/2a cln-081-001 trial showed the clinical benefit of cln-081 in patients with egfr exon 20 insertion-positive non small cell lung cancer. #nsclc #asco22 
Oncology news and insights from leading researchers and cancer centers.